ArticleOncology research2024

Piperlongumine in combination with EGFR tyrosine kinase inhibitors for the treatment of lung cancer cells.

Shail Rakesh Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.